The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Amyloid-β production in aged guinea pigs: atropine-induced enhancement is reversed by naloxone
Abstract
Advanced age, cholinergic deficit, and elevated brain levels of enkephalin are associated with sporadic Alzheimer's disease. The influence of these factors on production of amyloidogenic peptides (Abeta) is uncertain. In the present experiments, the levels of 40/42 amino acid-residue Abeta were measured in the brain cortex of guinea pigs aged 15-16 weeks (young) and 25-26 months (aged). As was found, injections of atropine (21 days, 5mg/kg/day) increase Abeta levels in aged but not young animals. This atropine-induced effect was antagonized by simultaneous injections of naloxone (3mg/kg/day) whereas naloxone alone failed to affect Abeta accumulation. These results are discussed in the light of a possible "acetylcholine - Abeta" feedback loop and an influence of enkephalin on the loop function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in animal models, reduced cholinergic transmission via atropine or cortical cholinergic denervation increased amyloid beta concentrations.38-40”
From Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study (2015) · cites this paper as [38]
In the citing paper
“The mechanism by which anticholinergic medications might contribute to dementia risk has not been elucidated; however, a few lines of evidence suggest that it is biologically plausible.”
From Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study (2015) · cites this paper as [38]
Citations
Cites
Yankner, B. A., Lu, T., & Loerch, P. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.2.010506.092044 · Cited by 677
Wang, J., Dickson, D. W., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7085 · Cited by 567
Flagged first, then by citations
Research works printed but not linked: 39
- Alessio, 1988, Age-related changes of methionine-enkephalin and β-endorphin/β-lipotropin immunoreactivity in human CSF, Life Sci., 43, 1545, 10.1016/0024-3205(88)90403-1 · DOI
- Beach, 2000, Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition, Neurosci. Lett., 283, 9, 10.1016/S0304-3940(00)00916-2 · DOI · Paper page
- Beach, 2001, Reduction of cortical amyloid β levels in guinea pig brain after systemic administration of physostigmine, Neurosci. Lett., 310, 21, 10.1016/S0304-3940(01)02076-6 · DOI
- Beck, 2003, Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo, Neurochem. Res., 28, 637, 10.1023/A:1022850113083 · DOI
- Bhargava, 1978, Effects of methionine-enkephalin and morphine on spontaneous locomotor activity, antagonism by naloxone, Pharmacol. Biochem. Behav., 9, 167, 10.1016/0091-3057(78)90160-0 · DOI
- Bloom, 1976, Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness, Science, 194, 630, 10.1126/science.185694 · DOI
- Davis, 1982, Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type, Psychopharmacol. Bull., 18, 193
- Fishman, 1975, Comparative in vivo distribution of opiate agonists and antagonists by means of double isotope techniques, Life Sci., 17, 1119, 10.1016/0024-3205(75)90333-1 · DOI
- Forgon, 1998, β-Peptide and its fragments induce acetylcholine release in in vitro basal forebrain tissue slices of rat brain, but do not affect the choline uptake, Neurobiology (Bp), 6, 359
- Fratiglioni, 2000, Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology, 54, S10
- Haddjeri, 2004, In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system, Int. J. Neuropsychopharmacol., 7, 391, 10.1017/S1461145704004377 · DOI
- Hellström-Lindahl, 2004, Reduced levels of Aβ40 and Aβ42 in brains of smoking controls and Alzheimer's patients, Neurobiol. Dis., 15, 351, 10.1016/j.nbd.2003.11.024 · DOI
- Hellström-Lindahl, 2009, Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease, Neurochem. Int., 55, 243, 10.1016/j.neuint.2009.03.007 · DOI
- Hung, 1993, Activation of protein kinase C inhibits cellular production of the amyloid β-protein, J. Biol. Chem., 268, 22959, 10.1016/S0021-9258(19)49409-X · DOI
- Ionov, 2007, Specific mechanism for blood inflow stimulation in brain area prone to Alzheimer's disease lesions, Int. J. Neurosci., 117, 1425, 10.1080/00207450601125733 · DOI
- Jhamandas, 1977, Enkephalin effects on release of brain acetylcholine, Nature, 269, 433, 10.1038/269433a0 · DOI
- Jhamandas, 1980, Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide, Br. J. Pharmacol., 71, 201, 10.1111/j.1476-5381.1980.tb10927.x · DOI
- Jia, 2004, Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia, Chin. Med. J. (Engl.), 117, 1161
- Jorm, 1998, The incidence of dementia: a meta-analysis, Neurology, 51, 728, 10.1212/WNL.51.3.728 · DOI · Paper page
- Kandasamy, 1983, Hyperthermic responses to central injections of some peptide and non-peptide opioids in the guinea-pig, Neuropharmacology, 22, 621, 10.1016/0028-3908(83)90154-5 · DOI
- Lord, 1977, Endogenous opioid peptides, multiple agonists and receptors, Nature, 267, 495, 10.1038/267495a0 · DOI · Paper page
- Meilandt, 2008, Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease, J. Neurosci., 28, 5007, 10.1523/JNEUROSCI.0590-08.2008 · DOI
- Mizuno, 1996, Medial septal injection of naloxone elevates acetylcholine release in the hippocampus and induces behavioral seizures in rats, Brain Res., 713, 1, 10.1016/0006-8993(95)01287-7 · DOI
- Ogomori, 1989, β-Protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease, Am. J. Pathol., 134, 243
- Petanceska, 2000, Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain, Exp. Gerontol., 35, 1317, 10.1016/S0531-5565(00)00157-1 · DOI
- Risser, 1996, Endogenous opioids in frontal cortex of patients with Down syndrome, Neurosci. Lett., 203, 111, 10.1016/0304-3940(95)12275-3 · DOI
- Rocha-de-Melo, 2008, Chronic neonatal exposure of rats to the opioid antagonist naloxone impairs propagation of cortical spreading depression in adulthood, Neurosci. Lett., 441, 315, 10.1016/j.neulet.2008.06.057 · DOI
- Roher, 2000, Cortical cholinergic denervation elicits vascular Aβ deposition, Ann. N. Y. Acad. Sci., 903, 366, 10.1111/j.1749-6632.2000.tb06388.x · DOI · Paper page
- Ruzicka, 1988, Depression of potassium-evoked striatal acetylcholine release by δ-receptor activation: inhibition by cholinoactive agents, Can. J. Physiol. Pharmacol., 66, 1487, 10.1139/y88-243 · DOI
- Selkoe, 2001, Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein, J. Alzheimers Dis., 3, 75, 10.3233/JAD-2001-3111 · DOI · Paper page
- Steger, 1980, Reduced ability of naloxone to stimulate LH and testosterone release in aging male rats; possible relation to increase in hypothalamic met5-enkephalin, Life Sci., 27, 747, 10.1016/0024-3205(80)90328-8 · DOI
- Steinerman, 2008, Distinct pools of β-amyloid in Alzheimer disease-affected brain: a clinicopathologic study, Arch. Neurol., 65, 906, 10.1001/archneur.65.7.906 · DOI · Paper page
- Svedberg, 2009, [(11)C]PIB-amyloid binding and levels of Aβ40 and Aβ42 in postmortem brain tissue from Alzheimer patients, Neurochem. Int., 54, 347, 10.1016/j.neuint.2008.12.016 · DOI
- Teng, 2010, A GPCR/secretase complex regulates β- and γ-secretase specificity for Aβ production and contributes to AD pathogenesis, Cell Res., 20, 138, 10.1038/cr.2010.3 · DOI
- Tohgi, 1994, Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia, Neurosci. Lett., 177, 139, 10.1016/0304-3940(94)90064-7 · DOI
- Tohgi, 1996, Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia, J. Neural. Transm., 103, 1211, 10.1007/BF01271206 · DOI
- Verdile, 2004, Protein markers for Alzheimer disease in the frontal cortex and cerebellum, Neurology, 63, 1385, 10.1212/01.WNL.0000141848.45315.A6 · DOI
- White, 1977, Neocortical cholinergic neurons in elderly people, Lancet, 1, 668, 10.1016/S0140-6736(77)92114-6 · DOI
- Zou, 2006, Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid β and impairment of learning and memory, J. Pharmacol. Exp. Ther., 317, 334, 10.1124/jpet.105.095687 · DOI
Cited by
Sorted by citations
Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study
Gray, S. L., Anderson, M. L., Dublin, S., Hanlon, J. T., Hubbard, R., Walker, R., Yu, O., Crane, P. K., & Larson, E. B. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7663 · Cited by 1,111
Metadata
- Authors
- Ionov, I. D., & Pushinskaya, I. I.
- Affiliations
- Russian Academy of Sciences (RU)
- ORCID
- Ionov, Ilya D.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 480
- Issue
- 1
- Pages
- 83-86
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2064848141
- Cited by
- 11
- References
- 2
- Citations by year
- 2026: 1 · 2024: 3 · 2022: 1 · 2020: 1 · 2018: 1 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 0.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- amyloid-beta, Alzheimer's disease, aging, atropine, naloxone, cholinergic deficit, enkephalin, acetylcholine, cerebral cortex, guinea pig
- MeSH terms
- Aging, Animals, Atropine, Cerebral Cortex, Enkephalins, Guinea Pigs, Male, Naloxone, Narcotic Antagonists, Amyloid beta-Peptides, Muscarinic Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review